Year |
Citation |
Score |
2024 |
West J, Rentzeperis F, Adam C, Bravo R, Luddy KA, Robertson-Tessi M, Anderson ARA. Tumor-immune metaphenotypes orchestrate an evolutionary bottleneck that promotes metabolic transformation. Frontiers in Immunology. 15: 1323319. PMID 38426105 DOI: 10.3389/fimmu.2024.1323319 |
0.518 |
|
2022 |
Strobl MAR, Gallaher J, West J, Robertson-Tessi M, Maini PK, Anderson ARA. Spatial structure impacts adaptive therapy by shaping intra-tumoral competition. Communications Medicine. 2: 46. PMID 35603284 DOI: 10.1038/s43856-022-00110-x |
0.338 |
|
2022 |
Gatenbee CD, Baker AM, Schenck RO, Strobl M, West J, Neves MP, Hasan SY, Lakatos E, Martinez P, Cross WCH, Jansen M, Rodriguez-Justo M, Whelan CJ, Sottoriva A, Leedham S, ... Robertson-Tessi M, et al. Immunosuppressive niche engineering at the onset of human colorectal cancer. Nature Communications. 13: 1798. PMID 35379804 DOI: 10.1038/s41467-022-29027-8 |
0.447 |
|
2021 |
West J, Schenck RO, Gatenbee C, Robertson-Tessi M, Anderson ARA. Normal tissue architecture determines the evolutionary course of cancer. Nature Communications. 12: 2060. PMID 33824323 DOI: 10.1038/s41467-021-22123-1 |
0.372 |
|
2020 |
Strobl MAR, West J, Viossat Y, Damaghi M, Robertson-Tessi M, Brown JS, Gatenby RA, Maini PK, Anderson ARA. Turnover modulates the need for a cost of resistance in adaptive therapy. Cancer Research. PMID 33172930 DOI: 10.1158/0008-5472.CAN-20-0806 |
0.344 |
|
2020 |
Park DS, Luddy KA, Robertson-Tessi M, O'Farrelly C, Gatenby RA, Anderson ARA. Searching for Goldilocks: How evolution and ecology can help uncover more effective patient-specific chemotherapies. Cancer Research. PMID 32934022 DOI: 10.1158/0008-5472.Can-19-3981 |
0.362 |
|
2020 |
Lakatos E, Williams MJ, Schenck RO, Cross WCH, Househam J, Zapata L, Werner B, Gatenbee C, Robertson-Tessi M, Barnes CP, Anderson ARA, Sottoriva A, Graham TA. Evolutionary dynamics of neoantigens in growing tumors. Nature Genetics. PMID 32929288 DOI: 10.1038/S41588-020-0687-1 |
0.522 |
|
2019 |
Nichol D, Robertson-Tessi M, Anderson ARA, Jeavons P. Model genotype-phenotype mappings and the algorithmic structure of evolution. Journal of the Royal Society, Interface. 16: 20190332. PMID 31690233 DOI: 10.1098/Rsif.2019.0332 |
0.327 |
|
2019 |
Park DS, Robertson-Tessi M, Luddy KA, Maini PK, Bonsall MB, Gatenby RA, Anderson ARA. The Goldilocks Window of Personalized Chemotherapy: Getting the Immune Response Just Right. Cancer Research. PMID 31387920 DOI: 10.1158/0008-5472.Can-18-3712 |
0.558 |
|
2019 |
Robertson-Tessi M, El-Kareh A, Goriely A. Corrigendum to ``A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy'' [Journal of Theoretical Biology 380 (2015) 569-584]. Journal of Theoretical Biology. 464: 181. PMID 30610835 DOI: 10.1016/J.Jtbi.2018.12.040 |
0.648 |
|
2019 |
Robertson-Tessi M, El-Kareh A, Goriely A. Corrigendum to ``A mathematical model of tumor-immune interactions'' [Journal of Theoretical Biology 294 (2012) 56-73]. Journal of Theoretical Biology. 464: 180. PMID 30610834 DOI: 10.1016/J.Jtbi.2018.12.041 |
0.638 |
|
2019 |
Kim E, Gallaher J, Robertson-Tessi M, Smalley I, Gatenby R, Smalley K, Zhang J, Eroglu Z, Anderson ARA. Abstract SY38-02: Personalized adaptive therapy for metastatic cancer: An integrated approach Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Sy38-02 |
0.506 |
|
2018 |
Mailloux AW, Rana F, Yagawa Y, Robertson-Tessi M, Susan ZL, Anderson ARA, Mulé JJ. Abstract B17: A dual in vivo and in silico system to model ectopic lymph node structure formation and antitumor immune response in the murine tumor microenvironment Cancer Research. 78. DOI: 10.1158/1538-7445.Mousemodels17-B17 |
0.608 |
|
2017 |
Yagawa Y, Robertson-Tessi M, Zhou SL, Anderson ARA, Mulé JJ, Mailloux AW. Systematic Screening of Chemokines to Identify Candidates to Model and Create Ectopic Lymph Node Structures for Cancer Immunotherapy. Scientific Reports. 7: 15996. PMID 29167448 DOI: 10.1038/S41598-017-15924-2 |
0.522 |
|
2017 |
Ibrahim-Hashim A, Robertson-Tessi M, Enrizues-Navas P, Damaghi M, Balagurunathan Y, Wojtkowiak JW, Russell S, Yoonseok K, Lloyd MC, Bui MM, Brown JS, Anderson AR, Gillies RJ, Gatenby RA. Defining cancer subpopulations by adaptive strategies rather than molecular properties provides novel insights into intratumoral evolution. Cancer Research. PMID 28249898 DOI: 10.1158/0008-5472.Can-16-2844 |
0.487 |
|
2016 |
Poleszczuk J, Luddy KA, Prokopiou S, Robertson-Tessi M, Moros EG, Fishman M, Djeu JY, Finkelstein SE, Enderling H. Abscopal benefits of localized radiotherapy depend on activated T cell trafficking and distribution between metastatic lesions. Cancer Research. PMID 26833128 DOI: 10.1158/0008-5472.Can-15-1423 |
0.521 |
|
2015 |
Robertson-Tessi M, El-Kareh A, Goriely A. A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy. Journal of Theoretical Biology. 380: 569-84. PMID 26087282 DOI: 10.1016/J.Jtbi.2015.06.009 |
0.674 |
|
2015 |
Robertson-Tessi M, Gillies RJ, Gatenby RA, Anderson AR. Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes. Cancer Research. 75: 1567-79. PMID 25878146 DOI: 10.1158/0008-5472.Can-14-1428 |
0.563 |
|
2015 |
Robertson-Tessi M, Anderson AR. Big Bang and context-driven collapse. Nature Genetics. 47: 196-7. PMID 25711865 DOI: 10.1038/Ng.3231 |
0.377 |
|
2015 |
Robertson-Tessi M, Park D, Luddy K, Mailloux A, Burnette PK, Anderson A. Abstract A86: Harnessing T-cell homeostasis to diagnose and treat solid and liquid tumors Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-A86 |
0.511 |
|
2015 |
Prokopiou S, Poleszczuk J, Robertson-Tessi M, Luddy KA, Fishman M, Moros E, Djeu JY, Enderling H. Abstract A19: Systems biology approach predicts the diagnostic value of T effector: T regulatory cell ratio in clinical response to combined radiation/immunotherapy of high-risk soft tissue sarcoma Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-A19 |
0.568 |
|
2015 |
Poleszczuk J, Prokopiou S, Robertson-Tessi M, Luddy K, Moros E, Fishman M, Djeu J, Enderling H. Abstract A18: A systems biology approach to predict immunotherapy augmented abscopal effects Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-A18 |
0.556 |
|
2015 |
Robertson-Tessi M, Gillies RJ, Gatenby RA, Anderson AR. Abstract B05: Harnessing heterogeneity to design better combination therapies Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-B05 |
0.57 |
|
2014 |
Luddy KA, Robertson-Tessi M, Tafreshi NK, Soliman H, Morse DL. The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition. Frontiers in Immunology. 5: 429. PMID 25368611 DOI: 10.3389/Fimmu.2014.00429 |
0.539 |
|
2013 |
Robertson-Tessi M, Gillies RJ, Gatenby RA, Anderson ARA. Abstract A2: The importance of metabolic heterogeneity and its consequences on tumor invasion, metastatic growth, and treatment Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-A2 |
0.544 |
|
2012 |
Robertson-Tessi M, El-Kareh A, Goriely A. A mathematical model of tumor-immune interactions. Journal of Theoretical Biology. 294: 56-73. PMID 22051568 DOI: 10.1016/J.Jtbi.2011.10.027 |
0.665 |
|
2011 |
Robertson-Tessi M, Estrella VC, Chen T, Lloyd MC, Gillies RJ, Gatenby RA, Anderson ARA. Abstract 53: Exploiting heterogeneity to develop better treatment strategies using an evolutionary multiscale mathematical model of tumor-vessel interactions Cancer Research. 71: 53-53. DOI: 10.1158/1538-7445.Am2011-53 |
0.591 |
|
Show low-probability matches. |